Cargando…
Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study
Human hematopoietic stem/progenitor cell (HSPC)-based gene therapy is a promising direction for curing HIV-1-infected individuals. The zinc finger protein (2LTRZFP) designed to target the 2-LTR-circle junction of HIV-1 cDNA was previously reported as an intracellular antiviral molecular scaffold tha...
Autores principales: | Chupradit, Koollawat, Khamaikawin, Wannisa, Sakkhachornphop, Supachai, Puaninta, Chaniporn, Torbett, Bruce E., Borwornpinyo, Suparerk, Hongeng, Suradej, Wattanapanitch, Methichit, Tayapiwatana, Chatchai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875109/ https://www.ncbi.nlm.nih.gov/pubmed/35216446 http://dx.doi.org/10.3390/ijms23042331 |
Ejemplares similares
-
Modulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process
por: Moonmuang, Sutpirat, et al.
Publicado: (2018) -
A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors
por: Chupradit, Koollawat, et al.
Publicado: (2022) -
Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication
por: Chupradit, Koollawat, et al.
Publicado: (2022) -
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid Assembly
por: Khamaikawin, Wannisa, et al.
Publicado: (2015) -
Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
por: Nangola, Sawitree, et al.
Publicado: (2012)